[Tamoxifen promotes metastasis of breast cancer via reshaping lipid driven fibrotic microenvironments in the lung], 2026, Neoplasia
[IFI16/IFI202 blockade suppresses tumor growth through CD8+ T-cell-mediated immunity], 2026, Breast Cancer Research
[Gnetofuran A Enhances Osteoblast Differentiation through the p38 Signaling Pathway], 2025, Biomolecules & Therapeutics
[IFI16 Enhances Chemosensitivity of Breast Cancer Cells by Inhibiting DNA Damage Response], 2025, Biomolecules & Therapeutics
[Secreted LGALS3BP facilitates distant metastasis of breast cancer], 2025, Breast Cancer Research
[NR1D1 enhances antitumor immune responses via cGAS/STING signaling pathway in breast cancer], 2023, Cancer Research
[Targeting HMG-CoA synthase 2 suppresses tamoxifen-resistant breast cancer growth by augmenting mitochondrial oxidative stress-mediated cell death], 2023, Life Sciences
[IFI16/Ifi202 released from breast cancer induces secretion of inflammatory cytokines from macrophages and promotes tumor growth], 2023, Journal of Cellular Physiology
[LncRNA Ctcflos modulates glucocorticoid receptor-mediated induction of hepatic phosphoenolpyruvate carboxykinase in mice], 2023, Life Sciences
[Type I IFN stimulates IFI16-mediated aromatase expression in adipocytes that promotes E2-dependent growth of ER-positive breast cancer, 2022, Cellular and Molecular Life Sciences
[IFI16 inhibits DNA repair that potentiates type-I interferon-induced antitumor effects in triple negative breast cancer], 2021, Cell Reports
수행과제
연구분야
Cancer metabolism and metastasis
Tumor microenvironment and immunometabolic crosstalk
Therapeutic target discovery and translational validation